FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suzanne Fuqua

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Mouse

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Jeyanthy Eswaran; Liliana D Florea; Suzanne A W Fuqua; Sucheta Godbole; Anelia Horvath; Prakriti Mudvari; Sujit Nair; Kazufumi Ohshiro; Kornelia Polyak; Sirigiri Divijendra Reddy; Dinesh Cyanam; Rakesh Kumar
RNA sequencing of cancer reveals novel splicing alterations.
V Bartella; Stefania Catalano; Suzanne A W Fuqua; Cinzia Giordano; Francesca Giordano; Loredana Mauro; Maria Luisa Panno; Pietro Rizza; Diego Sisci; D Zito; Ines Barone; Sebastiano Andò
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.
Ines Barone; Daniela Bonofiglio; Gianluca Bossi; Stefania Catalano; Kyle R Covington; Suzanne A W Fuqua; Luca Gelsomino; Cinzia Giordano; Stefania Marsico; Salvatore Panza; Sebastiano Andò
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suzanne Fuqua (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeyanthy Eswaran; Liliana D Florea; Suzanne A W Fuqua; Sucheta Godbole; Anelia Horvath; Prakriti Mudvari; Sujit Nair; Kazufumi Ohshiro; Kornelia Polyak; Sirigiri Divijendra Reddy; Dinesh Cyanam; Rakesh Kumar
RNA sequencing of cancer reveals novel splicing alterations.
Scientific reports 2013;3():1689.
2012: V Bartella; Stefania Catalano; Suzanne A W Fuqua; Cinzia Giordano; Francesca Giordano; Loredana Mauro; Maria Luisa Panno; Pietro Rizza; Diego Sisci; D Zito; Ines Barone; Sebastiano Andò
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.
Breast cancer research and treatment 2012;134(2):569-81.
2012: Ines Barone; Daniela Bonofiglio; Gianluca Bossi; Stefania Catalano; Kyle R Covington; Suzanne A W Fuqua; Luca Gelsomino; Cinzia Giordano; Stefania Marsico; Salvatore Panza; Sebastiano Andò
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.
Cancer research 2012;72(6):1416-27.
2012: Jeyanthy Eswaran; Liliana Florea; Suzanne A W Fuqua; Sucheta Godbole; Prakriti Mudvari; Sujit S Nair; Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Dinesh Cyanam; Rakesh Kumar
Transcriptomic landscape of breast cancers through mRNA sequencing.
Scientific reports 2012;2():264.
2011: Jennifer Selever; Anna Tsimelzon; Heidi Weiss; Guowei Gu; Matthew H Herynk; Michael Lewis; Lucio Miele; Patrick Provost; Kathy Albain; Sebastiano Ando; Ines Barone; Amanda Beyer; Ahcène Boumendjel; Kyle R Covington; Attilio Di Pietro; gabriela dontu; Suzanne A W Fuqua
Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6510-21.
2011: Francesca De Amicis; Suzanne A W Fuqua; Francesca Giordano; Maria Luisa Panno; Michele Pellegrino; Donatella Tramontano; Adele Vivacqua; Sebastiano Andò
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(10):3695-707.
2011: Cinzia Giordano; S Panza; Pietro Rizza; D Vizza; Ines Barone; Daniela Bonofiglio; Stefania Catalano; Suzanne A W Fuqua; L Gelsomino; Sebastiano Andò
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
Oncogene 2011;30(39):4129-40.
2011: Ines Barone; Lauren Brusco; Guowei Gu; Jennifer Selever; Amanda Beyer; Kyle R Covington; Anna Tsimelzon; Tao Wang; Susan G Hilsenbeck; Gary C Chamness; Sebastiano Andò; Suzanne A W Fuqua
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
Journal of the National Cancer Institute 2011;103(7):538-52.
2011: Lyndsay Vanhoy Rhodes; Sarah P Short; Nicole F Neel; Virgilio A Salvo; Yun Zhu; Steven Elliott; Yongkun Wei; Dihua Yu; Menghong Sun; Shannon E Muir; Juan P Fonseca; Melyssa R Bratton; Chris Segar; Syreeta Latatia Tilghman; Tammy Sobolik-Delmaire; Linda W Horton; Snjezana Zaja-Milatovic; Bridgette M Collins-Burow; Scott Wadsworth; Barbara S Beckman; Charles E Wood; Suzanne A W Fuqua; Kenneth P Nephew; Paul Dent; Rebecca A Worthylake; Tyler J Curiel; Mien-Chie Hung; Ann Richmond; Matthew Burow
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.
Cancer research 2011;71(2):603-13.
2010: Matthew H Herynk; Torsten A Hopp; Yukun Cui; Airu Niu; Arnoldo Corona-Rodriguez; Suzanne A W Fuqua
A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
Breast cancer research and treatment 2010;122(2):381-93.
2010: Ines Barone; Lauren Brusco; Suzanne A W Fuqua
Estrogen receptor mutations and changes in downstream gene expression and signaling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2702-8.
2010: Kazufumi Ohshiro; Prakriti Mudvari; Qing-chang Meng; Suresh K Rayala; Aysegul A Sahin; Suzanne A W Fuqua; Rakesh Kumar
Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator.
Molecular endocrinology (Baltimore, Md.) 2010;24(5):914-22.
2010: Francesca De Amicis; Janagi Thirugnansampanthan; Yukun Cui; Jennifer Selever; Amanda Beyer; Irma Parra; Nancy L Weigel; Matthew H Herynk; Anna Tsimelzon; Michael Lewis; Gary C Chamness; Susan G Hilsenbeck; Sebastiano Andò; Suzanne A W Fuqua
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
Breast cancer research and treatment 2010;121(1):1-11.
2010: Cinzia Giordano; Yukun Cui; Ines Barone; Sebastiano Ando; Michael A Mancini; Valeria Berno; Suzanne A W Fuqua
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.
Breast cancer research and treatment 2010;119(1):71-85.
2009: Adele Vivacqua; Rosamaria Lappano; Paola De Marco; Diego Sisci; Saveria Aquila; Francesca De Amicis; Suzanne A W Fuqua; Sebastiano Andò; Marcello Maggiolini
G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.
Molecular endocrinology (Baltimore, Md.) 2009;23(11):1815-26.
2009: Matthew H Herynk; Michael Lewis; Torsten A Hopp; Daniel Medina; A Corona-Rodriguez; Yukun Cui; A R Beyer; Suzanne A W Fuqua
Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
Oncogene 2009;28(36):3177-87.
2009: Daniela Bonofiglio; Erika Cione; Hongyan Qi; Attilio Pingitore; Mariarita Perri; Stefania Catalano; Donatella Vizza; Maria Luisa Panno; Giuseppe Genchi; Suzanne A W Fuqua; Sebastiano Andò
Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
The American journal of pathology 2009;175(3):1270-80.
2009: Jenny C Chang; Susan G Hilsenbeck; Suzanne A W Fuqua
Pharmacogenetics of breast cancer: toward the individualization of therapy.
Cancer investigation 2009;27(7):699-703.
2009: Ines Barone; Yukun Cui; Matthew H Herynk; Arnoldo Corona-Rodriguez; Cinzia Giordano; Jennifer Selever; Amanda Beyer; Sebastiano Andò; Suzanne A W Fuqua
Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
Cancer research 2009;69(11):4724-32.
2007: Matthew H Herynk; Irma Parra; Yukun Cui; Amanda Beyer; Meng-Fen Wu; Susan G Hilsenbeck; Suzanne A W Fuqua
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3235-43.
2007: Matthew H Herynk; Suzanne A W Fuqua
Estrogen receptors in resistance to hormone therapy.
Advances in experimental medicine and biology 2007;608():130-43.
2006: Matthew H Herynk; Amanda R Beyer; Yukun Cui; Heidi Weiss; Elizabeth Anderson; Tim P Green; Suzanne A W Fuqua
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
Molecular cancer therapeutics 2006;5(12):3023-31.
2006: Carlos A Ramos; Teresa A Bowman; Nathan C Boles; Akil A Merchant; Yayun Zheng; Irma Parra; Suzanne A W Fuqua; Chad A Shaw; Margaret A Goodell
Evidence for diversity in transcriptional profiles of single hematopoietic stem cells.
PLoS genetics 2006;2(9):e159.
2006: Yukun Cui; Airu Niu; Richard G Pestell; Rakesh Kumar; Edward M Curran; Yunde Liu; Suzanne A W Fuqua
Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 2006;20(9):2020-35.
2006: Yukun Cui; Irma Parra; Mao Zhang; Susan G Hilsenbeck; Anna Tsimelzon; Toru Furukawa; Akira Horii; Zhong-Yin Zhang; Robert I Nicholson; Suzanne A W Fuqua
Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.
Cancer research 2006;66(11):5950-9.
2005: Rajesh R Singh; Christopher J Barnes; Amjad H Talukder; Suzanne A W Fuqua; Rakesh Kumar
Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Cancer research 2005;65(22):10594-601.
2005: Stephanie Sommer; Yukun Cui; Gary Brewer; Suzanne A W Fuqua
The c-Yes 3'-UTR contains adenine/uridine-rich elements that bind AUF1 and HuR involved in mRNA decay in breast cancer cells.
The Journal of steroid biochemistry and molecular biology 2005;97(3):219-29.
2005: Indira Poola; Suzanne A W Fuqua; Robert L De Witty; Jessy Abraham; Josephine J Marshallack; Aiyi Liu
Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7579-85.
2005: Suzanne A W Fuqua; Yukun Cui; Adrian V Lee; C Kent Osborne; Kathryn B Horwitz
Insights into the role of progesterone receptors in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):931-2; author reply 932-3.
2005: Jenny C Chang; Susan G Hilsenbeck; Suzanne A W Fuqua
The promise of microarrays in the management and treatment of breast cancer.
Breast cancer research : BCR 2005;7(3):100-4.
2004: Yukun Cui; Mao Zhang; Richard G Pestell; Edward M Curran; Wade V Welshons; Suzanne A W Fuqua
Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity.
Cancer research 2004;64(24):9199-208.
2004: Matthew H Herynk; Suzanne A W Fuqua
Estrogen receptor mutations in human disease.
Endocrine reviews 2004;25(6):869-98.
2004: Torsten A Hopp; Heidi L Weiss; Irma Parra; Yukun Cui; C Kent Osborne; Suzanne A W Fuqua
Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7490-9.
2004: Linda A de Graffenried; Torsten A Hopp; Anthony Valente; Robert Clark; Suzanne A W Fuqua
Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1 and ERalpha.
Breast cancer research and treatment 2004;85(2):111-20.
2004: Torsten A Hopp; Heidi L Weiss; Susan G Hilsenbeck; Yukun Cui; D Craig Allred; Kathryn B Horwitz; Suzanne A W Fuqua
Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2751-60.
2004: Suzanne A W Fuqua; Jenny C Chang; Susan G Hilsenbeck
Genomic approaches to understanding and treating breast cancer.
Breast disease 2004;19():35-46.
2004: Suzanne A W Fuqua; Yukun Cui
Estrogen and progesterone receptor isoforms: clinical significance in breast cancer.
Breast cancer research and treatment 2004;87 Suppl 1():S3-10.
2003: Suzanne A W Fuqua; Rachel Schiff; Irma Parra; John T Moore; Syed K Mohsin; C Kent Osborne; Gary M Clark; D Craig Allred
Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.
Cancer research 2003;63(10):2434-9.
2003: C Kent Osborne; Valerie Bardou; Torsten A Hopp; Gary C Chamness; Susan G Hilsenbeck; Suzanne A W Fuqua; Jiemin Wong; D Craig Allred; Gary M Clark; Rachel Schiff
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.
Journal of the National Cancer Institute 2003;95(5):353-61.
2002: Linda A de Graffenried; Susan G Hilsenbeck; Suzanne A W Fuqua
Sp1 is essential for estrogen receptor alpha gene transcription.
The Journal of steroid biochemistry and molecular biology 2002;82(1):7-18.
2002: Maofu Fu; Chenguang Wang; Jian Wang; Xueping Zhang; Toshiyuki Sakamaki; Yee-Guide Yeung; Chawnshang Chang; Torsten A Hopp; Suzanne A W Fuqua; Ellis Jaffray; Ron Thomas Hay; Jorma J Palvimo; Olli A Jänne; Richard G Pestell
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.
Molecular and cellular biology 2002;22(10):3373-88.
2002: Suzanne A W Fuqua; Yukun Cui
Targeting the estrogen receptor in clinical breast cancer.
Breast disease 2002;15():3-11.
2001: C Kent Osborne; Rachel Schiff; Suzanne A W Fuqua; Jiang Shou
Estrogen receptor: current understanding of its activation and modulation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12 Suppl):4338s-4342s; discussion 4411s-4412s.
2001: Suzanne A W Fuqua
The role of estrogen receptors in breast cancer metastasis.
Journal of mammary gland biology and neoplasia 2001;6(4):407-17.
2001: H H Zhao; Rafael E Herrera; EB Coronado-Heinsohn; M C Yang; John H Ludes-Meyers; K J Seybold-Tilson; Zafar Nawaz; D Yee; F G Barr; Sami Diab; Powel H Brown; Suzanne A W Fuqua; C Kent Osborne
Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions.
The Journal of biological chemistry 2001;276(30):27907-12.
2001: Chenguang Wang; Maofu Fu; Ruth Hogue Angeletti; Linda Siconolfi-Baez; Anne T Reutens; Chris Albanese; Michael P Lisanti; Benita S Katzenellenbogen; S Kato; Torsten A Hopp; Suzanne A W Fuqua; Gabriela N Lopez; Peter J Kushner; Richard G Pestell
Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.
The Journal of biological chemistry 2001;276(21):18375-83.
2001: Rhonda K Hansen; Irma Parra; S G Hilsenbeck; B Himelstein; Suzanne A W Fuqua
Hsp27-induced MMP-9 expression is influenced by the Src tyrosine protein kinase yes.
Biochemical and biophysical research communications 2001;282(1):186-93.
2001: D Craig Allred; Syed K Mohsin; Suzanne A W Fuqua
Histological and biological evolution of human premalignant breast disease.
Endocrine-related cancer 2001;8(1):47-61.
2001: Suzanne A W Fuqua; J Russo; S E Shackney; M E Stearns
Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer.
Postgraduate medicine 2001;Spec No():3-10.
2000: Rachel Schiff; P Reddy; M Ahotupa; EB Coronado-Heinsohn; M Grim; Susan G Hilsenbeck; R Lawrence; SM Deneke; Rafael E Herrera; Gary C Chamness; Suzanne A W Fuqua; Powel H Brown; C Kent Osborne
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.
Journal of the National Cancer Institute 2000;92(23):1926-34.
2000: Jui-Lan Su; David D McKee; Byron Ellis; Sue H Kadwell; G Bruce Wisely; Linda B Moore; J A Triantafillou; Thomas A Kost; Suzanne A W Fuqua; John T Moore
Production and characterization of an estrogen receptor beta subtype-specific mouse monoclonal antibody.
Hybridoma 2000;19(6):481-7.
2000: C Kent Osborne; H Zhao; Suzanne A W Fuqua
Selective estrogen receptor modulators: structure, function, and clinical use.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3172-86.
2000: Suzanne A W Fuqua; C Wiltschke; Q X Zhang; A Borg; C G Castles; WE Friedrichs; Torsten A Hopp; Susan G Hilsenbeck; Syed K Mohsin; Peter O'Connell; D Craig Allred
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Cancer research 2000;60(15):4026-9.
2000: S Koduri; Suzanne A W Fuqua; Indira Poola
Alterations in the estrogen receptor alpha mRNA in the breast tumors of African American women.
Journal of cancer research and clinical oncology 2000;126(5):291-7.
2000: Steffi Oesterreich; Q Zhang; Torsten A Hopp; Suzanne A W Fuqua; M Michaelis; H H Zhao; James Davie; C Kent Osborne; Adrian V Lee
Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
Molecular endocrinology (Baltimore, Md.) 2000;14(3):369-81.
1999: Suzanne A W Fuqua; Rachel Schiff; Irma Parra; WE Friedrichs; Jui-Lan Su; David D McKee; KA Slentz-Kesler; Linda B Moore; Timothy M Willson; John T Moore
Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
Cancer research 1999;59(21):5425-8.
1999: Steffi Oesterreich; Suzanne A W Fuqua
Tumor suppressor genes in breast cancer.
Endocrine-related cancer 1999;6(3):405-19.
1999: Peter O'Connell; Karl-Friedrich Fischbach; Susan G Hilsenbeck; Syed K Mohsin; Suzanne A W Fuqua; Gary M Clark; C Kent Osborne; D Craig Allred
Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.
Journal of the National Cancer Institute 1999;91(16):1391-7.
1999: Rhonda K Hansen; Irma Parra; P Lemieux; Steffi Oesterreich; Susan G Hilsenbeck; Suzanne A W Fuqua
Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.
Breast cancer research and treatment 1999;56(2):187-96.
1999: Susan G Hilsenbeck; WE Friedrichs; Rachel Schiff; Peter O'Connell; Rhonda K Hansen; C Kent Osborne; Suzanne A W Fuqua
Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.
Journal of the National Cancer Institute 1999;91(5):453-9.
1998: Peter O'Connell; V Pekkel; Suzanne A W Fuqua; C Kent Osborne; Gary M Clark; D Craig Allred
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
Journal of the National Cancer Institute 1998;90(9):697-703.
1998: Torsten A Hopp; Suzanne A W Fuqua
Estrogen receptor variants.
Journal of mammary gland biology and neoplasia 1998;3(1):73-83.
1997: Steffi Oesterreich; Adrian V Lee; T M Sullivan; SK Samuel; James Davie; Suzanne A W Fuqua
Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells.
Journal of cellular biochemistry 1997;67(2):275-86.
1997: Rhonda K Hansen; Steffi Oesterreich; P Lemieux; K D Sarge; Suzanne A W Fuqua
Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells.
Biochemical and biophysical research communications 1997;239(3):851-6.
1997: C G Castles; Steffi Oesterreich; R Hansen; Suzanne A W Fuqua
Auto-regulation of the estrogen receptor promoter.
The Journal of steroid biochemistry and molecular biology 1997;62(2-3):155-63.
1997: Q X Zhang; Ake Borg; D M Wolf; Steffi Oesterreich; Suzanne A W Fuqua
An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.
Cancer research 1997;57(7):1244-9.
1996: Q X Zhang; S G Hilsenbeck; Suzanne A W Fuqua; Ake Borg
Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.
The Journal of steroid biochemistry and molecular biology 1996;59(3-4):251-60.
1996: C G Castles; D Craig Allred; S L Krieg; M G Benedix; Suzanne A W Fuqua
RNA from air-dried frozen sections for RT-PCR and differential display.
BioTechniques 1996;21(3):425-8.
1996: Steffi Oesterreich; Susan G Hilsenbeck; Daniel R Ciocca; D Craig Allred; Gary M Clark; Gary C Chamness; C Kent Osborne; Suzanne A W Fuqua
The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1199-206.
1996: Steffi Oesterreich; E Hickey; Lee A Weber; Suzanne A W Fuqua
Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells.
Biochemical and biophysical research communications 1996;222(1):155-63.
1996: P Lemieux; Suzanne A W Fuqua
The role of the estrogen receptor in tumor progression.
The Journal of steroid biochemistry and molecular biology 1996;56(1-6 Spec No):87-91.
1995: Suzanne A W Fuqua; D M Wolf
Molecular aspects of estrogen receptor variants in breast cancer.
Breast cancer research and treatment 1995;35(3):233-41.
1995: DM Klotz; C G Castles; Suzanne A W Fuqua; LL Spriggs; Steven M Hill
Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness.
Biochemical and biophysical research communications 1995;210(2):609-15.
1995: C G Castles; DM Klotz; Suzanne A W Fuqua; Steven M Hill
Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.
British journal of cancer 1995;71(5):974-80.
1995: D M Wolf; Suzanne A W Fuqua
Mechanisms of action of antiestrogens.
Cancer treatment reviews 1995;21(3):247-71.
1994: Richard M Elledge; Gary M Clark; Suzanne A W Fuqua; Y Y Yu; D Craig Allred
p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
Cancer research 1994;54(14):3752-7.
1994: Peter M Ravdin; A K Tandon; D Craig Allred; Gary M Clark; Suzanne A W Fuqua; S H Hilsenbeck; Gary C Chamness; C Kent Osborne
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):467-74.
1994: C A Encarnacion; Suzanne A W Fuqua
Estrogen receptor variants in breast cancer.
Cancer treatment and research 1994;71():97-109.
1994: D Craig Allred; Richard M Elledge; G M Clark; Suzanne A W Fuqua
The p53 tumor-suppressor gene in human breast cancer.
Cancer treatment and research 1994;71():63-77.
1994: Suzanne A W Fuqua; M G Benedix; S Krieg; C N Weng; Gary C Chamness; Steffi Oesterreich
Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells.
Breast cancer research and treatment 1994;32(2):177-86.
1994: Suzanne A W Fuqua; Steffi Oesterreich; Susan G Hilsenbeck; Daniel Von Hoff; J Eckardt; C Kent Osborne
Heat shock proteins and drug resistance.
Breast cancer research and treatment 1994;32(1):67-71.
1994: Peter O'Connell; V Pekkel; Suzanne A W Fuqua; C Kent Osborne; D Craig Allred
Molecular genetic studies of early breast cancer evolution.
Breast cancer research and treatment 1994;32(1):5-12.
1994: C Kent Osborne; Suzanne A W Fuqua
Mechanisms of tamoxifen resistance.
Breast cancer research and treatment 1994;32(1):49-55.
1994: D Craig Allred; Peter O'Connell; Suzanne A W Fuqua; C Kent Osborne
Immunohistochemical studies of early breast cancer evolution.
Breast cancer research and treatment 1994;32(1):13-8.
1993: C G Castles; Suzanne A W Fuqua; DM Klotz; Steven M Hill
Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Cancer research 1993;53(24):5934-9.
1993: Q X Zhang; Ake Borg; Suzanne A W Fuqua
An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
Cancer research 1993;53(24):5882-4.
1993: Daniel R Ciocca; Steffi Oesterreich; Gary C Chamness; W L McGuire; Suzanne A W Fuqua
Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.
Journal of the National Cancer Institute 1993;85(19):1558-70.
1993: Steffi Oesterreich; C N Weng; M Qiu; Susan G Hilsenbeck; C Kent Osborne; Suzanne A W Fuqua
The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Cancer research 1993;53(19):4443-8.
1993: Daniel R Ciocca; Gary M Clark; A K Tandon; Suzanne A W Fuqua; W J Welch; W L McGuire
Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications.
Journal of the National Cancer Institute 1993;85(7):570-4.
1993: D Craig Allred; Gary M Clark; Richard M Elledge; Suzanne A W Fuqua; R W Brown; Gary C Chamness; C Kent Osborne; W L McGuire
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.
Journal of the National Cancer Institute 1993;85(3):200-6.
1993: Suzanne A W Fuqua; Gary C Chamness; W L McGuire
Estrogen receptor mutations in breast cancer.
Journal of cellular biochemistry 1993;51(2):135-9.
1993: Richard M Elledge; Suzanne A W Fuqua; Gary M Clark; P Pujol; D Craig Allred
William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.
Breast cancer research and treatment 1993;27(1-2):95-102.
1993: C A Encarnación; Daniel R Ciocca; W L McGuire; Gary M Clark; Suzanne A W Fuqua; C Kent Osborne
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
Breast cancer research and treatment 1993;26(3):237-46.
1993: Richard M Elledge; Suzanne A W Fuqua; Gary M Clark; P Pujol; D Craig Allred; W L McGuire
Prognostic significance of p53 gene alterations in node-negative breast cancer.
Breast cancer research and treatment 1993;26(3):225-35.
1993: Suzanne A W Fuqua; D Craig Allred; Richard M Elledge; S L Krieg; M G Benedix; Zafar Nawaz; Bert W O'Malley; G L Greene; W L McGuire
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.
Breast cancer research and treatment 1993;26(2):191-202.
1992: W L McGuire; Gary C Chamness; Suzanne A W Fuqua
Abnormal estrogen receptor in clinical breast cancer.
The Journal of steroid biochemistry and molecular biology 1992;43(1-3):243-7.
1992: Daniel R Ciocca; Suzanne A W Fuqua; S Lock-Lim; D O Toft; W J Welch; W L McGuire
Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
Cancer research 1992;52(13):3648-54.
1992: Suzanne A W Fuqua; S D Fitzgerald; D Craig Allred; Richard M Elledge; Zafar Nawaz; D P McDonnell; Bert W O'Malley; G L Greene; W L McGuire
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.
Cancer research 1992;52(2):483-6.
1992: W L McGuire; Gary C Chamness; Suzanne A W Fuqua
The importance of normal and abnormal oestrogen receptor in breast cancer.
Cancer surveys 1992;14():31-40.
1991: W L McGuire; G C Chamness; Suzanne A W Fuqua
Estrogen receptor variants in clinical breast cancer.
Molecular endocrinology (Baltimore, Md.) 1991;5(11):1571-7.
1991: Suzanne A W Fuqua; Steven M Hill; Gary C Chamness; M G Benedix; G L Greene; Bert W O'Malley; W L McGuire
Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors.
Journal of the National Cancer Institute 1991;83(16):1157-60.
1991: Ake Borg; H Sigurdsson; G M Clark; Mårten Fernö; Suzanne A W Fuqua; Håkan Olsson; Dick Killander; W L McGurie
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.
British journal of cancer 1991;63(1):136-42.
1991: Suzanne A W Fuqua; S D Fitzgerald; Gary C Chamness; A K Tandon; D P McDonnell; Zafar Nawaz; Bert W O'Malley; W L McGuire
Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
Cancer research 1991;51(1):105-9.
1990: Suzanne A W Fuqua; S D Fitzgerald; W L McGuire
A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts.
BioTechniques 1990;9(2):206-11.
1990: Ake Borg; A K Tandon; H Sigurdsson; G M Clark; Mårten Fernö; Suzanne A W Fuqua; Dick Killander; W L McGuire
HER-2/neu amplification predicts poor survival in node-positive breast cancer.
Cancer research 1990;50(14):4332-7.
1990: N S Falette; Suzanne A W Fuqua; Gary C Chamness; M S Cheah; G L Greene; W L McGuire
Estrogen receptor gene methylation in human breast tumors.
Cancer research 1990;50(13):3974-8.
1990: Suzanne A W Fuqua; N F Falette; W L McGuire
Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay.
Journal of the National Cancer Institute 1990;82(10):858-61.
1989: C Kent Osborne; E B Coronado; L J Kitten; C I Arteaga; Suzanne A W Fuqua; K Ramasharma; M Marshall; C H Li
Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Molecular endocrinology (Baltimore, Md.) 1989;3(11):1701-9.
1989: Suzanne A W Fuqua; M Blum-Salingaros; W L McGuire
Induction of the estrogen-regulated "24K" protein by heat shock.
Cancer research 1989;49(15):4126-9.
1989: D E Merkel; Suzanne A W Fuqua; A K Tandon; S M Hill; A U Buzdar; W L McGuire
Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1129-36.
1989: S E McGuire; Suzanne A W Fuqua; Susan Naylor; D A Helin-Davis; W L McGuire
Chromosomal assignments of human 27-kDa heat shock protein gene family.
Somatic cell and molecular genetics 1989;15(2):167-71.
1989: D E Merkel; Suzanne A W Fuqua; W L McGuire
P-glycoprotein in breast cancer.
Cancer treatment and research 1989;48():97-105.
1989: Suzanne A W Fuqua; D E Merkel; W L McGuire
Laboratory aspects of multidrug resistance.
Cancer treatment and research 1989;42():45-59.
1989: Steven M Hill; Suzanne A W Fuqua; Gary C Chamness; G L Greene; W L McGuire
Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.
Cancer research 1989;49(1):145-8.
1988: C Kent Osborne; C R Ross; E B Coronado; Suzanne A W Fuqua; L J Kitten
Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.
Breast cancer research and treatment 1988;11(3):211-9.
1988: I Moretti-Rojas; Suzanne A W Fuqua; R A Montgomery; W L McGuire
A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells.
Breast cancer research and treatment 1988;11(2):155-63.
1988: D E Merkel; Suzanne A W Fuqua; S M Hill; W L McGuire
P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens.
Progress in clinical and biological research 1988;276():61-73.